UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Tetracycline Derivatives
Situation
The Tetracycline Derivatives class review and formulary standardization was approved at the June 2021 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: eravacycline, omadacycline, tigecycline, sarecycline
Assessment/Recommendations
Changes Effective: Tuesday, August 31, 2021
System P&T voted to include the following products on the UNC Health System Drug Formulary:
- Eravacycline, powder for reconstitution: 50 mg vial
As a result, the following products will be removed from the inpatient drug formulary:
- Tigecycline, powder for reconstitution: 50 mg vial